For those seeking core competencies and updates in heart failure care, this specific learning pathway features Maintenance of Certification credits and is designed with online summaries of key takeaways from “Ten Simple Tips” and “Clinical Conundrums” sessions at the 2019 HFSA ASM. These session provide up to 14.50 CME Credits/ MOC points.

HFSA’s 2019 Core Learning Path is intended for physicians, nurses, nurse practitioners, pharmacists, scientists, and health care professionals who specialize or have an interest  in heart failure.

Co-Chair(s)

Ten Simple Tips: Strategies for Heart Failure Prevention (AHA Joint Session) Moderator(s): Sheryl Chow; Michele Hamilton Clinically Applicable Biomarkers for Early Detection of HF  Speaker: Alan Maisel Trifecta of Lifestyle Modifications: Diet, Exercise, and Cardiac Rehab  Speaker: Ileana Pina Risk Factor Moderation Using Pharmacologic Therapy  Speaker: Orly Vardeny Model for Primary Care Providers and Telehealth  Speaker: Farruk Merchant Ten Simple Tips for Managing Complexities of Cardiogenic Shock Moderator(s): Maya Guglin; Michael Givertz When to Pull the Trigger on Acute MCS  Speaker: Jorge Silva Enciso Which Pump in What Scenario -- IABP vs Impella vs Tandem Heart?  Speaker: Arvind Bhimaraj ECMO for Cardiogenic Shock  Speaker: Edward Soltesz RV Support in Cardiiogenic Shock  Speaker: Arthur Garan Pharmacologic Management in the Percutaneous Mechanical Circulatory Support Patient  Speaker: Rob Didomenico Ten Simple Tips: Identifying the Ever-Elusive Volume Overload in the Clinic Moderator(s): Tariq Ahmad; Sara Paul Why Do HF Patients Experience Volume Overload?  Speaker: Tariq Ahmad Assessing Congestion - Is There a Role for History and Physical Exam  Speaker: Jennifer Thibodeau Serum Biomarkers to Diagnose and Treat Congestion  Speaker: James Januzzi Ultrasound at the Bedside: Portable Ultrasound and Echocardiography to Evaluate for Congestion  Speaker: Amil Shah Using Implantable Sensors and Impedanace to Assess and Optimize Volume Status  Speaker: Divya Gupta Direct Blood Volume Measurement to Assess Congestion - Is It Necessary? Can We Afford It?  Speaker: Wayne Miller Ten Simple Tips: Implementation of Technologies to Assist in HF Care and Reduce Readmissions (Joint Session ACC) Moderator(s): J. Thomas Heywood; Gurusher Panjrath Quality Metrics for HF Care: What Has the Life Span of a Housefly Taught Us?  Speaker: Marvin Konstam Systems of Care Strategies to Enhance HF Care- pharmacists, Navigators, Paramedics and Beyond  Speaker: Mary Walsh Queuing Theory to Redesign Access to HF Care Post Hospitalization  Speaker: Clyde Yancy Using the Current Digital World to Optimize HF Care at Home: Apps to Apple Watches  Speaker: Ashish Atreja Engineering Solutions for HF: Collaborations to Enhance Innovations in Care for HF as a Chronic Disease Speaker: Gerard Cote Clinical Conundrums in Pharmacologic Therapy for HFrEF: Case-Based Approaches Moderator(s): Jean Nappi; Kavita Sharma Physician Panelist (Cases 1-3)  Panelist: Faiez Zannad Nurse Panelist (Cases 1-3)  Panelist: Marie Galvao Pharmacist Panelist (Cases 1-3)  Panelist: Kerry Pickworth Physician Panelist (Cases 1-3)  Panelist: Kirkwood Adams Pharmacist Panelist (Cases 1-3)  Panelist: Jo Ellen Rodgers Nurse Panelist (Cases 1-3)  Panelist: Sara Paul Ten Simple Tips: Cardiac Amyloidosis: No Longer an Academic Exercise, Now a Treatable Pandemic (ASNC Joint Session) Moderator(s): James Udelson; Daniel Judge Cardiac Amyloidosis: Road to Diagnosis and a Race Against Time  Speaker: Mazen Hanna  Role of Imaging in Diagnosis: Has Endomyocardial Biopsy Become Obsolete?  Speaker: Omar F. Abou Ezzeddine Cardiologists’ Amyloid Polyneuropathy Primer  Speaker: Sami Khella 2019 Update on Management of Transthyretin Amyloidosis  Speaker: Mathew Maurer 2019 Update on Management of Light Chain Amyloidosis  Speaker: Vaishali Sanchorawala Advanced Therapies for Amyloidosis: No Longer an Absolute Contraindication for Some  Speaker: Justin Grodin Clinical Conundrums: Managing AFIb and Device Therapies in HF - Case Based Debates (HRS Joint Session) Moderator(s): Mike Dickinson; Andrea Russo Debate 1: PRO - AF Ablation Should Be an Early Rhythm Management Strategy for Advanced HF  Speaker: Douglas Packer Debate 1: CON - AF Ablation Should Be an Early Rhythm Management Strategy for Advanced HF  Speaker: Andrea Russo Debate 2 : PRO - Patients W/recovered Ejection Fraction Should Undergo Routine Defribillator Generator Change or Replacement to Prevent Sudden Cardiac Death Risk Speaker: Lynne Warner Stevenson Debate 2: CON - Patients W/recovered Ejection Fraction Should Undergo Routine Defribillator Generator Change or Replacement to Prevent Sudden Cardiac Death Risk Speaker: Wayne Levy Debate 3: PRO - Imaging-based Device Optimization Should Be Routinely Performed Following Implantation of Cardiac Resynchronization Therapy Speaker: Wilfried Mullens Debate 3 : CON - Imaging-based Device Optimization Should Be Routinely Performed Following Implantation of Cardiac Resynchronization Therapy Speaker: John J. Rickard Ten Simple Tips for Treating Patients with Diabetes and HF (ADA Joint Session) Moderator(s): Kirkwood Adams; Anita Deswal Diabetes and Cardiovascular Risk: Focus on HF  Speaker: David Aguilar SGLT2 Inhibitors and GLP1 Receptor Agonists in Diabetes and HF: Mechanisms to Clinical Trials  Speaker: Javed Butler Glucose-lowering Agents to Improve Cardiorespiratory Fitness in HF  Speaker: Salvatore Carbone Renal Considerations in Treatment of Diabetes with HF  Speaker: Akshay Desai The Endocrinology Perspective: Management of Diabetes in Patients W/hf- what Goals, What Meds, and by Whom? Speaker: Christina Mitchell Ten Simple Tips: How to Best Treat Volume Overload in HF: From Medications to Machines Moderator(s): Jeffrey Testani; Steven Hollenberg Creative Strategies for Teaching Patients How to Adjust Diruretics  Speaker: Audry Kleet Treating Volume Overload with Good Ol' Diuretics: What's Works Best?  Speaker: G. Michael Felker Augmenting Decongestion: When to Use IV Vasodilators and Inotropic Support  Speaker: Ian Hollis Rise of the Machines: Renal Replacement & Device Therapies to Remove Fluid in Patients W/volume Overload Speaker: Bradley Bart Therapeutic Innovations to Decongest Patients Hospitalized for Volume Overload  Speaker: Marat Fudim Ten Simple Tips: Managing Patients Across the Spectrum of Pulmonary Hypertension (Joint Session PHA) Moderator(s): Jeremy Mazurek; Marc Simon The Approach to the Patient w/Pulmonary Arterial Hypertension: Case Presentation  Case Presenter: Sophia Airhart The Approach to the Patient w/Pulmonary Arterial Hypertension: Discussant  Speaker: Anjali Vaidya The Approach to the Patient w/Pulmonary Hypertension and Sickle Cell Disease: Case Presentation  Case Presenter: Sriram Rao The Approach to the Patient with Pulmonary Hypertension and Sickle Cell Disease: Case Discussant  Speaker: Marc Simon The Approach to the Patient w/Complex Mitral Valve Disease and Severe Pulmonary Vascular Disease: Case Presentation Case Presenter: Mitchell Psotka The Approach to the Patient w/Complex Mitral Valve Disease and Severe Pulmonary Vascular Disease: Case - Discussant Case Discussant: Mardi Gomberg-Maitland The Approach to the Patient w/Sleep Apnea and Pulmonary Hypertension: Case Presentation  Case Presenter: Ashrith Guha The Approach to the Patient w/Sleep Apnea and Pulmonary Hypertension: Discussant  Case Discussant: Susan Joseph The Approach to the Patient w/Chronic Thromboembolic Pulmonary Hypertension: Case Presentation  Case Presenter: Jeremy Mazurek The Approach to the Patient w/Chronic Thromboembolic Pulmonary Hypertension: Discussant  Case Discussant: Paul Forfia

Physicians

 

The Heart Failure Society of America (HFSA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

HFSA designates this live activity for a maximum of 14.5 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

 

Successful completion of this CME activity, which includes participation in the evaluation component and post-test with 75% passing score, enables the participant to earn up to 14.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Akshay Desai, MD – Brigham and Women's Hospital Research Grant: Astrazeneca, Alnylam, Novartis; Consultant-Advisory Board: Abbott, Astrazeneca, Alnylam, Boehringer Ingelheim, Boston Scientific, Biofourmis, DalCor, Relypsa, Regeneron, Novar-tis
Amil Shah, MD – Brigham and Women's Hospital Research Grant: Novartis; Consultant-Advisory Board: Philips Ultrasound, Bellerophon Therapeutics
Andrea Russo, MD – Cooper University Health Center --  Camden Research Grant: Boehringer Ingelheim, Boston Scientific; Consultant-Advisory Board: Boston Scientific Steering Committee (no honoraria); Apple Res. Steering Committee (no  honoraria)
Arthur Garan, MD – Columbia University Consultant-Advisory Board: Abiomed
Arvind Bhimaraj, MD – Houston Methodist Hospital Consultant-Advisory Board: Abiomed; Abbott
Ashrith Guha, MD – Houston Methodist Hospital Speaker-Honoraria: Bayer Inc., Johnson & Johnson
Daniel Judge, MD – Medical Unviersity of South Carolina -- Charleston Consultant-Advisory Board: Pfizer, 4DMT, Blade Therapeutics
Douglas Packer, MD – Mayo Clinic Research Grant: Abbott, Biosense, Webster, boston Scientific, CardioFocus, CardioIn-sight/Medtronic, Medtronic, St. Jude Medical, Thermedical; Consultant-Advisory Board: Abbott, Biosense Webster, Boston Scientific, Biotronik, CardioFocus, Johnson & Johnson, Medtronic, St. Jude Medical, Thermedical
Edward Soltesz, MD – Cleveland Clinic Honoraria-Speaker: Abbott, Abiomed; Ownership Interest: Jace Medical; Consultant-Advisory Board: Atricure; 
Ileana Pina, MD, MPH – Wayne State University Consultant-Advisory Board:  Relypsa, FDA, CDRH
Orly Vardeny, PharmD – University of Minnesota Medical School Research Grant: Astrazeneca; Consultant-Advisory Board: Novartis
James Januzzi, MD – Massachusetts General Hospital Research Grant: Roche, Abbott, Prevencio, Siemens; Consultant-Advisory Board: : Roche, Abbott, Prevencio, Siemens
James Udelson, MD – Tufts New England Medical Center – Research Grant: Pfizer, Cyclerion, Bayer, LivaNova; Consultant-Advisory Board: Cyclerion, Bayer, Lan-theus, LivaNova, Cardurion
Javed Butler, MD, MPH – University of Mississippi Research Grant: NIH, European Union, PCORI; Consultant-Advisory Board: Amgen, Array, Astra-zeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, CVRx, G3 Pharmaceutical, Innolife, Janssen, Luitpold, Medtronic, Merck, Novartis, Relypsa, Stealth Peptide, SC Pharma, Vifor
Jennifer Thibodeau, MD – UT Southwestern Medical Center Research Grant: Novartis 
Jeremy Mazurek, MD – University of Pennsylvania – Philadelphia Research Grant: United Therapeutics, Actelion Pharmaceuticals, Tenax, Corvia, Complexa; Consultant-Advisory Board: United Therapeutics
Jo Ellen Rodgers, PharmD – University of North Carolina Research Grant: Novartis
John J. Rickard, MD, MBA – Cleveland Clinic Research Grant: Abbott; Speaker-Honoraria: Abbott; Consultant-Advisory Board: Medtronic
Justin Grodin, MD, MPH – UT Southwestern Consultant-Advisory Board: Pfizer
Kavita Sharma, MD – John’s Hopkins University -- Baltimore Speaker-Honoraria: Novartis; Consultant-Advisory Board: Novartis
Kirkwood Adams, MD – The University of North Carolina at Chapel Hill Research Grant: Otsuka, Roche Diagnostics, BMS, Amgen, Boehringer Ingelheim, Merk, Novartis; Consultant-Advisory Board: Relypsa, Cytokinetics, Amgen, Novartis
Marat Fudim, MD – Duke University Consultant-Advisory Board: Axon Therapies, Cordidea, Galvani
Mardi Gomberg-Maitland, MD – George Washington University Consultant-Advisory Board: Janssen/Actelion, Reata, Complexa, Acceleron, United Therapeutics
Mathew Maurer, MD – Research Grant: Pfizer, Eidos; Consultant-Advisory Board: Pfizer, Alnylam, Eidos, Akcea
Mazen Hanna, MD – Cleveland Clinic Consultant-Advisory Board: Pfizer, Akcea, Alnylam, Eidos
G. Michael Felker, MD – Duke University Research Grant: NHLBI, American Heart Association, Amgen, Merck, Cytokinetics, Roche; Consult-ant-Advisory Board: Amgen, Roche, Novartis, Bristol Meyers Squibb, Medtronic, Cardionormic
Michele Hamilton, MD – Cedars Sinai, Beverly Hills Consultant-Advisory Board: Abbott
Omar F. Abou Ezzeddine, MD – Mayo Clinic Research Grant: Pfizer, Inc.
Sami Khella, MD – Penn Medicine Research Grant: Lonis; Consultant-Advisory Board: Alnylam, Lonis, Pfizer
J. Thomas Heywood, MD – Scripps, La Jolla Research Grant: Abbott, Impedimed, VitalMetrics; Speaker-Honoraria: Abbott, Medtronic, Novartis, Actelion, Boehringer-Ingelheim; Consultant-Advisory Board: Medtronic, Impedimed, VitalMetrics, Boston Scientific
Wayne Levy, MD – University of Washington Research Grant: NIH, Novartis; Ownership Interest: Amarin; Consultant-Advisory Board: Medtron-ic, CardioMems/St. Jude Medical/Abbott/Bairn, Evalve, Cardiac Dimensions, Impulse Dynamics, Respircardia, EBR Systems, Inc.
Wayne Miller, MD – Mayo Clinic Research Grant: Daxor Corp, Feldschuh Foundation for Clinical Research